Kayo Nishiguchi Selected Research

Salts

10/2023	A Serine Protease Inhibitor, Camostat Mesilate, Suppresses Urinary Plasmin Activity and Alleviates Hypertension and Podocyte Injury in Dahl Salt-Sensitive Rats.
1/2023	The serine protease plasmin plays detrimental roles in epithelial sodium channel activation and podocyte injury in Dahl salt-sensitive rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kayo Nishiguchi Research Topics

Disease

2	Hypertension (High Blood Pressure) 10/2023 - 01/2023
2	Proteinuria 10/2023 - 01/2023
1	Infections 01/2022
1	COVID-19 01/2022

Drug/Important Bio-Agent (IBA)

2	camostatIBA 10/2023 - 01/2023
2	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 10/2023 - 01/2023
2	Fibrinolysin FDA Link 10/2023 - 01/2023
2	SaltsIBA 10/2023 - 01/2023
1	Peptide Hydrolases (Proteases)FDA Link 01/2023
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2023
1	2- methylthio- N6- threonylcarbamoyladenosineIBA 01/2022
1	N(6)-(N-threonylcarbonyl)adenosineIBA 01/2022
1	NucleosidesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022